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Key Points: 
 We developed state-of-the-art deep convolutional networks to perform fully automated 
segmentation of malignant lesions in breast MRI using a large dataset consisting of 
2,555 segmented malignant breasts and 60,108 benign breasts. 
 The best performing network, a 3D U-Net operating on MRI contrast enhancement 
dynamic, achieves radiologist-level performance on an independent test set of 250 
breasts with a Dice score of 0.77 and radiologist performance of 0.69-0.84. 
 We make the code and pretrained network freely available to facilitate future studies on 
volumetric evaluation of malignant lesions.
Abstract
Purpose: The goal of this research was to develop a deep network architecture that achieves 
fully-automated radiologist-level segmentation of breast tumors in MRI.  
Materials and Methods: We leveraged 38,229 clinical MRI breast exams collected 
retrospectively from women aged 12-94 (mean age 54) who presented between 2002 and 2014 
at a single clinical site. The training set for the network consisted of 2,555 malignant breasts that
were segmented in 2D by experienced radiologists, as well as 60,108 benign breasts that 
served as negative controls. The test set consisted of 250 exams with tumors segmented 
independently by four radiologists.  We selected among several 3D deep convolutional neural 
network architectures, input modalities and harmonization methods. The outcome measure was 
the Dice score for 2D segmentation, and was compared between the network and radiologists 
using the Wilcoxon signed-rank test and the TOST procedure.
Results: The best-performing network on the training set was a volumetric U-Net with contrast 
enhancement dynamic as input and with intensity normalized for each exam. In the test set the 
median Dice score of this network was 0.77. The performance of the network was equivalent to 
that of the radiologists (TOST procedure with radiologist performance of 0.69-0.84 as 
equivalence bounds: p = 5e-10 and p = 2e-5, respectively; N = 250) and compares favorably 
with published state of the art (0.6-0.77).
Conclusion: When trained on a dataset of over 60 thousand breasts, a volumetric U-Net 
performs as well as expert radiologists at segmenting malignant breast lesions in MRI. 
Introduction
Segmentation of breast tumors provides image features such as shape, morphology, texture, 
and enhancement dynamics that can improve diagnosis and prognosis in breast cancer patients
(1–4). Reliable automated tumor segmentation does not yet exist, and manual segmentation is 
labor-intensive; this has precluded routine clinical evaluation of tumor volume despite mounting 
evidence that it is a good predictor of patient survival (3). Automatic segmentation with modern 
deep network techniques has the potential to meet this clinical need. Deep learning methods 
have been applied in breast tumor segmentation (5,6) and diagnosis (7–12) in mammograms, 
where large datasets of up to one million images are available, which greatly boosts the 
performance of the machine-learning systems (13,14). Yet unlike MRI, mammograms cannot 
determine the exact 3D location and volumetric extent of a lesion. Breast MRI has higher 
diagnostic accuracy than mammography (15–17) and outperforms mammograms in detecting 
residual tumors after neoadjuvant therapy (18). Additionally, background parenchymal 
enhancement (BPE) measured in MRI with dynamic contrast enhancement is predictive of 
cancer risk (19). Several studies have automated tumor segmentation in breast MRI using 
modern deep learning techniques such as U-Nets or DeepMedic (20–26). Unfortunately, the 
available MRI datasets have remained comparatively small (~300 cases or less); therefore,  
performance has been limited, with Dice scores in the range of 0.60-0.77. At present, trained 
radiologists outperform automated methods on MRI segmentation (21). We hypothesize that 
human-level performance can be achieved if a sufficiently large dataset is used to train a 
modern deep convolutional network. The goal of this research was to develop a deep-network 
architecture that achieves fully-automated radiologist-level segmentation of breast tumors in 
MRI by leveraging a dataset of over 60 thousand breast MRIs.
Materials and Methods
Study Design
We retrospectively accessed 38,229 clinical MRI breast exams performed for high-risk 
screening or diagnosis between 2002–2014, and partitioned them into training and test data at 
random (see Fig. 1, Table S1).
Segmentation was implemented in a deep network as a binary classification of every voxel in 
the MRI volume. To train the network, tumor voxels (classified as positive) were taken from 2D 
segmentations performed by dedicated breast radiologists. Negative examples were voxels 
taken from a central MRI slice of healthy breasts. Therefore, the network was trained to 
distinguish malignant from benign voxels, possibly including voxels in benign lesions. 
Using the training data, we first selected the best performing network architecture, established 
the utility of the available imaging sequences, and selected an effective harmonization 
procedure. 
We then compared the segmentations produced by the final network to those produced by 
trained radiologists in a separate test set of malignant cases segmented independently by four 
radiologists in 2D. Benign exams were not included in this analysis. The goal of this analysis 
was to determine if the performance of the network is equivalent to the performance of breast 
radiologists.
Human Subjects
This study was approved by the Institutional Review Board and written informed consent was 
waived due to the retrospective nature of this study. All data handling complied with HIPAA 
regulations.  
The patient population included 11,929 women who were enrolled in a screening program 
following established guidelines (27) and 2,546 women who were referred for diagnostic 
workup. The age range of the patient population was 12–94 years (mean age 52 years). The 
data included 3,955 breasts with biopsy-confirmed malignant tumors as well 60,108 breasts with
benign pathology, defined here as BIRADS 1, 2, and 3 with two-year tumor-free follow-up. The 
types of tumors included in the study are listed in Fig. S1.
Figure 1: Number of exams and breasts used in training and testing. See also Table S1.
Data Description and Harmonization 
All breast MRI examinations were acquired on either a 1.5 or 3.0 Tesla GE scanner (GE 
Medical Systems, Waukesha, WI). Exams were acquired in the sagittal plane (Fig. 2A) at 
varying in-plane resolutions (Fig. 2B), 2–4 mm slice thickness, and varying repetition times (TR) 
and echo times (TE). Each MRI exam contained T1, T2, and a variable number (N = 3–8) of T1 
post-contrast images (T1c) sampled with varying time intervals. All images used fat saturation. 
In-plane sagittal resolution was harmonized by upsampling relatively low resolution images by a 
factor of two (Fig. 2B). Images intensity from different scanners were harmonized by dividing 
with the 95th percentile of pre-contrast T1 intensity. To summarize the dynamic contrast 
enhancement (DCE) we measure the volume transfer constant for the initial uptake and 
subsequent washout, DCE-in and DCE-out respectively (Fig 2A; DCE-in is the first post-contrast
minus pre-contrast image; DCE-out is the intensity slope of all post-contrast images). Data 
collection, preprocessing and harmonization are described in more detail in the Supplement. 
Figure 2. A: Example of pre- and first post-contrast images, T1 and T1c, respectively. Initial dynamic contrast 
enhancement in this tumor-positive case is evident after subtraction of the aligned T1c  and T1 images (DCE-in). 
Subsequent washout (DCE-out) is evident in the subsequent contrast slope. B: T1c scans accrue over the years with 
a range of in-plane resolutions.
Radiologist Segmentations
All segmentations were performed in 2D slices by dedicated breast radiologists (R1–R10, years 
of experience: 5, 8, 5, 5, 8, 12, 7, 13, 5, 2) using exams where cancer was proven through a 
biopsy. To train the network, 2,694 breasts were segmented by individual radiologists (R1–
R10). These segmentations were subsequently reviewed by R1-R5 to ensure they met the 
inclusion criteria, resulting in 2,555 segmentations used for training (Fig. 1 and Table S1). To 
evaluate machine and human performance on independent test data an additional 266 breast 
cancers were independently segmented by all four radiologists (R1–R4). The common 2D slice 
to be segmented was selected by R5, containing the largest area of the index cancer. 
Radiologists performed segmentations on the T1c image, with the T1 and fat-saturated T2-
weighted images available for reference. For the test data, we also provided the T1c-T1 
subtraction (DCE-in) which quantifies initial uptake. See the Supplement for more details. 
Convolutional Neural Networks
We used networks based on the DeepMedic network (28) and a 3D U-Net (21), which have 
been used extensively for medical segmentation, including breast segmentation (20–25). The 
architecture of the 3D U-Net is described in Fig. 3 (Fig. S3 for the DeepMedic). Following 
previous studies (29) the traditional space-invariant implementation has been augmented by 
adding a spatial prior as input to the final classification. For the U-Net, the spatial prior was a 
breast mask, as in previous studies (21). This breast mask was computed using a separate U-
Net operating on the entire image at lower resolution. This network was trained on a smaller 
number of manually segmented breast slices (N = 100; performed by the first author). To avoid 
blocking artifacts that are often observed in U-Nets (30) carefully re-designed the conventional 
downsampling and upsampling steps. The 3D U-Net had approximately three million 
parameters. Details of the architectures, sampling, and training of the network parameters are in
the Supplement (Fig. S3, S4).
Figure 3: Deep convolutional network used for segmentation. We used a 3D U-Net with a total of 16 
convolutional layers (orange arrows) resulting in 3D feature maps (blue blocks). The input MRI includes several 
modalities (see Fig. 2A). The network output is a prediction for a 2D sagittal slice, with probabilities for malignancy for
each voxel (green/red map). The full volume is processed in non-overlapping image patches (green square on ‘Input 
MRI’). A breast mask provides a spatial prior as input to the U-Net.
Primary Outcome Measure
The network estimates for each voxel the probability of malignancy (Fig. 4). A binary 
segmentation was obtained by thresholding this probability at a fraction of the maximum in the 
selected slice (Fig. 4) and dismissing disconnected areas that did not reach the maximum. The 
primary outcome measure was the conventional Dice score (31) with a consensus segmentation
as reference (e.g. Fig. 4; and Supplement for detail). A Dice score of 1.0 corresponds to perfect 
overlap and a score of 0.0 indicates no overlap. 
Statistical Methods: 
All pairwise performance comparisons among different network architectures and between the 
network and radiologists used the Wilcoxon signed-rank test on the Dice score. We tested for 
equivalence in the Dice score of human and machine using TOST procedure (32). In this 
procedure performance is compared to bottom and top equivalence bounds, for which we 
selected the bottom and top performing radiologists. The comparisons were paired for the same
exams, and we again performed a Wilcoxon signed-rank test. 
Results:
To select the preferred network architecture, input modalities, and harmonization method we 
trained various architectures (as described in the Supplement). We evaluated performance on a
validation set, i.e. a fraction of the training data that is left out from training. Based on these 
results (Fig. S5) we selected a volumetric implementation of a 3D U-Net (Fig 3), which takes as 
inputs the first post contrast T1 (T1c), the initial uptake (T1c – T1), and the slope of the 
subsequent contrast (T1c-slope) (Fig. 2A). These sagittal images were aligned with deformable 
co-registration (33) covering the volume of a single breast. Intensity was harmonized by scaling 
each exam separately with a robust maximum of the pre-contrast T1.  When training this 
network on a dataset of different sizes we confirm the main hypothesis that the larger dataset 
significantly improves Dice score performance (0.63 for 240/240, 0.69 for 2,400/2,400, and 0.73 
for 2,455/60,108 malignant/benign scans respectively evaluated on a validation set of 100 
malignant scans; Fig. S6). 
Figure 4: Manual and automated segmentations of breast lesions. R1-R4: Example segmentation of 
all four radiologists for a given slice, T1c: first post-contrast, DCE-in: T1c-T1 subtraction, Ref1: 
intersection of R2–R4 which serves as unbiased reference for R1, M Probs: output of the network 
indicating probability that a voxel is a tumor (green = low; red = high). M: model segmentation created by 
thresholding these probabilities. Dice scores here are computed using Ref1. 
Performance of this final design was tested on an independent test of 266 malignant cases. 
Tumors were segmented independently by four breast radiologists (R1–R4) in a single 2D slice 
(Fig. 4). An unbiased reference segmentation was obtained for each radiologist using 
segmentations from the three remaining radiologists (e.g., Ref1 is the intersection of the 
segmentations of R2–R4 and is used to evaluate R1; Fig. 4). With this reference, we computed 
the receiver operating characteristic (ROC) curves (Fig. 5A for R1; Fig. S7A for R2–R4). The 
area under the ROC curve (AUC) is 0.996 when averaged over all 266 exams and the four 
references. The optimal threshold for converting continuous probabilities at the output of the 
network into binary segmentations was estimated using 16 exams of the test set (selected at 
random; Fig S7B). The Dice score of the remaining 250 exams of the test set (averaged over 
the four references) had a 5th–95th percentile range of 0.43–0.90 for the radiologists and 0.21–
0.92 for the network (Fig. 5B). These mean Dice scores did not differ significantly between the 
network and the radiologists (W=14034; p=0.15, N=250). The median Dice scores of the 
network were 0.76, 0.76, 0.77, and 0.76, and for the radiologists the median Dice scores were 
0.69, 0.84, 0.78, and 0.84, with one value for each of the four references. To test for 
equivalence, we performed the TOST procedure (32) with radiologists performance as the lower
and upper bounds for equivalence (R1 and R4, respectively; Fig. 5C). The Dice score of the 
network is significantly higher than that of R1 (W=9480; p=5e-8, N=250) and lower than that of 
R4 (W=11763; p=6e-4, N=250). In total, the mean performances of the network and the 
radiologists were indistinguishable, and median performance of the network was equivalent to 
that of the radiologists. 
Figure 5:  Network and radiologist performance on test set.  A: ROC curves of the segmentation network for all 
exams (blue) and performance of radiologist R1 (diamond) with the intersection of R2–R4 as reference segmentation.
The average ROC curve (black) had an AUC = 0.998. B: Distribution of Dice scores in 250 test cases averaged 
across four references did not differ between radiologists and the network (medians 0.79 and 0.77, respectively; 
Wilcoxon W=14034, p=0.15, N=250). C: Difference in Dice score between the network and each radiologist (Δ Dice) 
for each of the four reference segmentations. Each point represents one of the 250 test exams. The median Dice is 
higher for the network for Ref1 and Ref3 (orange) and higher for the radiologist for Ref2 and Ref4 (blue). (*: Wilcoxon
p < 0.05). 
  
There are several exams in which the network outperforms the average of the three radiologists 
(Δ Dice > 0, Fig. 5C; see Fig. 4 for an example). But in several instances, the network performs 
worse than the radiologists (Δ Dice < 0, Fig. 5C; see Fig. 6 for examples). The network deviates 
from the reference radiologist either in terms of the areas that it selected (Fig. 6A) or the tumor 
exact boundary (Fig. 6B). Network performance differed among tumor types (Fig. S8A), and 
was somewhat worse in the presence of prominent BPE (Fig. S8B). 
Figure 6: Examples of cases in which the network deviates from the segmentation of the reference
radiologist.  A: The network captures additional areas not selected by the radiologist R4. Dice score 
here shown for Ref4 (intersection of R1–R3). B: The network output (M Probs) captures the correct area, 
but after thresholding, low probability values yield a smaller region compared to the consensus 
segmentation (Ref2).
Discussion
We demonstrated radiologist-level performance in automated segmentation of breast tumor 
lesions in MRI by optimizing the architecture of deep convolutional networks using a large 
training dataset of MRI scans, which consisted of 2,555 malignant and 60,108 benign breasts. 
This dataset is substantially larger than previous efforts with deep networks, which used only 
50–250 MRI exams (20–25).  
We obtained the best performance with a volumetric U-Net that is conceptually simpler than 
previous networks (21,22,24). Complex structures with fewer parameters may have been 
necessary to compensate for the smaller data-set sizes used in these earlier studies. For 
instance, Zhang et al. combined three different 2D U-Nets in a hierarchical manner (21); one 
network generated a breast mask, the second produced segmentations of tumors, and the third 
refined these segmentations. We used a similar approach at first, following the MultiPrior 
network (29) with a breast mask as a spatial prior, and a conditional random field (CRF) for 
post-processing. However, we found that a simpler 3D U-Net without these additional modules 
sufficed. The U-Net also outperformend a DeepMedic (28), which we believe is the result of 
better integration of information at multiple spatial scales. Chen et al. used 2D U-Nets with a 
long-short-term-memory (LSTM) network at the input to process the contrast dynamic (22). 
Instead, we summarized the DCE in two images, capturing the initial contrast uptake and 
subsequent wash-out. This allowed us to harmonize the differing sampling intervals and the 
number of post-contrast images. Adoui et al. uses a Seg-Net which communicates only location 
information through residual connections. (24). This reduces the number of parameters as 
compared to a U-Net, and therefore may have required fewer training images. Other previous 
network methods cope with smaller training sets using pre-selected features (20), unsupervised 
clustering algorithm (25), or by leveraging shape priors (23).
Our final U-Net implementation differs from previous approaches in two important ways. First, 
we used a full 3D network instead of a conventional 2D network that processes individual slices 
independently (13,22,24–26). While this increased the number of network parameters, it also 
captured volumetric features missed in 2D processing. Our implementation also avoids 
sampling artIfacts encountered in conventional implementations of U-Nets (30). While we did 
this with an apparent increase in complexity, our approach obviates the need of less carefully 
designed architectures to “unlearn” sampling errors.
Previous efforts to apply machine learning to breast lesion segmentation report Dice scores in 
the range of 0.60–0.77 (20–24), but the performance of these models has generally not been 
compared to that of trained radiologists. In a head-to-head comparison, Zhang et al. (21) 
reported a Dice score of 0.72±0.28 for the network and 0.78+-0.30 for the radiologists. In the 
present study, automated segmentations matched the detailed segmentations of a trained 
radiologist with a Dice score of 0.77. Importantly, in the same dataset, we show statistical 
equivalence to radiologist performance in the range of 0.72–0.84. We note that the test set here 
includes difficult cases with small subcentimeter cancers, multicentric cancer and include 
patients with breast implants, all of which have often been excluded from previous studies. Our 
study is retrospective and limited to a single institution. However, the data set is heterogeneous 
having been collected over 12 years from different scanner types, magnet strengths (1.5 and 
3.0 Tesla), different breast coils, which results in variable spatial and temporal resolutions. All 
these factors together add to the difficulty and clinical realism of this study
The network classifies each voxel in the image and thus in principle provides volumetric 
segmentation. The main clinical utility is to facilitate volumetric assessment, which is not broadly
used despite proven benefit (1,3,4). It should be noted, however, that we evaluated automated 
segmentations only in 2D slices. Another limitation of the work is that we used sagittal images, 
which was standard practice at our institution until 2014, and which therefore characterized 
most of the historical data. Breast MRI protocols are often acquired in the axial plane and with 
continued improvements in technology, with higher temporal and spatial resolution. Thus, future 
studies should focus on volumetric evaluation of segmentations based on high-resolution multi-
planar breast MRI. To facilitate such studies we make all code and the pretrained network freely
available on github. 
In the clinic, radiologist-level performance in automated segmentation has the potential to aid 
detection and diagnosis and improve overall workflow of radiologists. In research, fast and 
accurate tumor segmentations might help identify important prognostic and predictive 
biomarkers and improve our understanding of breast cancer. 
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Supplementary Material
MRI exams 38,229
Scanned breasts 64,063
Biopsy-proven cancer 3,955
Benign breasts used for training
60,108
Malignant breasts used for training 2,555  1 radiologist⨯
Malignant breasts used for testing 266  4 radiologists⨯
(250 for testing, 16 for threshold tuning)
Table S1: Summary of available data used in training and testing. 
Figure S1: Number of tumors in the overall dataset. 
Data Description and Preprocessing
All breast MRI examination data were acquired with GE MRI scanners (GE Medical Systems, 
Waukesha, WI) with either a 1.5 or 3.0 Tesla fields and dedicated 4, 7, 8, or 16-channel breast 
coils. Five different scanner types were used: Signa Excite, Genesis Signa, Discovery, Signa 
HDxt and Optima MR450w. Exams were acquired in the sagittal plane (Fig. 2A) at various in-
plane resolutions (Fig. 2B), 2–4 mm lateral resolutions, and varying TR and TE times. 
Intravenous gadolinium-based contrast agent was administered at 0.10 mmol per kg of body 
weight and at a rate of 2 ml/sec. Prior to analysis, data were de-identified by removing all patient
information and by saving exams with anonymized patient identifiers. DICOM headers were 
used to identify the modality (T1 or T2), laterality (left or right breast), fat saturation, and 
acquisition time for pre- and post-contrast T1 images. In total, data was available for 38,229 
exams with complete imaging and diagnostic information for 64,063 breasts (not all exams 
included two breasts). 
Harmonization
To compensate for the diversity of data acquisition techniques in the 12-year period in which the
study data was collected, it was necessary to harmonize the spatial resolution, intensity, and 
contrast dynamics of the data. In-plane sagittal resolution was harmonized by upsampling low 
resolution images by a factor of two to approximately match higher resolution images (using the 
resize function in Python package scikit-image) (Fig 2B). Lateral resolution was left unchanged. 
Images from different scanners were harmonized by using intensity normalization, similar 
previous work (34). For this purpose, a breast mask was established for each T1 image (see 
below). Then, for each scanner, we computed a histogram of all breast voxels and calculated a 
nonlinear transformation to transform these histograms into a standard distribution (Fig. S2). We
deviate from (34) by using a Chi-square of degree k=4 as target distribution. This transformation
was then applied to all image intensities of that scanner, including pre- and post-contrast 
images. We also used an intensity harmonization based on each exam by dividing all images 
from an exam with the 95th percentile of the pre-contrast T1 intensity. This simpler exam-based 
alternative was ultimately adopted as it outperformed the scanner-based intensity harmonization
(see Fig. S5D below). Finally, to harmonize the contrast dynamic, we computed the initial 
uptake (DCE-in) and the intensity slope over time of the post-contrast MRIs to capture DCE 
wash-out (DCE-out) measured in units of min -1, i.e. volume transfer constants  (Fig.2A). This 
initial uptake and subsequent slope were computed after deformable co-registration with 
NiftyReg (33), where we used the first post-contrast image T1c as a common reference for all 
images. 
Figure S2. Intensity harmonization across different scanners to a standard Chi-square distribution: A: Intensity 
distribution of each scanner and B-field intensity (each distribution belongs to one of a total of six scanner 
manufacturers identified). B: Non-linear transformation mapping the intensities from each scanner to intensities of a 
target distribution (same colors as in panel A). C: Intensities distribution after the non-linear mapping transformation. 
They all approximate the target of a Chi-square distribution (with k=4). 
Radiologist Segmentations
From the available 3,955 confirmed malignant exams 2,694 exams were selected at random 
(Fig.1). Selected exams included all required sequences (T1, T1c, and T2), were of adequate 
image quality, and were free from gross imaging artifacts. Of these 2,694 exams, radiologists 
R5–R8 segmented an initial 880 exams, whereby segmentation was limited to the largest index 
cancer. Radiologists R1–R4 segmented an additional 1,814 exams, whereby segmentation 
included the entire extent of disease included in the 2D slice to provide the network a more 
complete sample of tumor voxels. Note that benign voxels for training are taken only from 
benign breasts, so that segmentations performed by R5-R8 on the largest index cancer can still 
be used for training. 
All breast cancer segmentations were reviewed by radiologists R1–R5 and exams were 
excluded in any of the following circumstances: significant post-surgical  change with partial 
resection of the cancer, post-biopsy change larger than 50% of the index cancer, MRI 
performed of breast cancer after having been treated with neoadjuvant chemotherapy, and 
inaccurate segmentation that was was missing more than 50% of the mass. Of the 2,694 
exams, 139 were excluded resulting in a total of 2,555 segmented breast cancer exams, which 
were used for network training. 
To evaluate machine and human performance on an independent test set, an additional 266 
confirmed-malignant exams were selected at random with the same inclusion/exclusion criteria. 
Each of these 266 tumors were segmented by all four radiologists (R1–R4), with the single 2D 
slice having already been selected by R5. These segmentations included the entire extent of the
disease.
Because most patients had multiple screening breast MRI, the dataset contains multiple scans 
of the same breast at different time points. After selecting the training/validation/testing 
partitions, any breasts that overlapped between them were removed from the training set.
Radiologists performed segmentations on the first post-contrast image (T1c) with the pre-
contrast T1 and T2 images available for reference, along with the existing radiology reports. For 
the test data, we also provided the initial uptake image (DCE-in). Segmentations were 
performed with a custom graphic user interface (based on the Tkinter Python toolbox) using a 
tablet or mouse (based on personal preference). 
The Dice score was used for evaluation of the segmentation generated by the network against 
the radiologist’s segmentation. This metric is common in segmentation tasks (21,29), and is 
defined as: Dice=2TP / (2TP+FP+FN ) where TP = true positives, FN = false negatives, and 
FP = false positives, corresponding to classified voxels against the defined reference.
Implementation Detail for DeepMedic
The DeepMedic network follows the implementation of Hirsch et al. (29) and was based on the 
architecture proposed in Kamnitsas et al. (28). The general architecture is shown in Fig. S3. 
The network consists of a 3D convolutional neural network (CNN) with 11 layers and
two parallel pathways. All layers contain learnable kernels (size 3⨯3⨯3) and ReLU 
as nonlinear activation functions, except the last classifcation layer, which has a 
Softmax activation function. During training, this network takes as input a patch of 
13⨯35⨯35 voxels around a target patch of 9⨯9 to be classifed and a larger feld-of-
view of 13⨯75⨯75 voxels at half-resolution for extracting contextual features. As 
with the 3D U-Net, we add a TPM to provide prior spatial information. Here the TPM 
was the average segmentation of the lesions in the training data for all breasts after rigid body 
registration. Prior probabilities for the target patch are extracted from a TPM and 
added as input to the fnal classifcation. This TPM is constructed by averaging the 
segmentations from the training set. The fnal three layers take the concatenated 
output of all three pathways as input and classify the target patch with fully 
connected layers and no additional spatial mixing (kernel size 1⨯1⨯1). In total, the 
DeepMedic network had approximately one million parameters.
Figure S3: The DeepMedic network processes an image section or patch at high-resolution (contoured in yellow) and
in parallel a larger patch (contoured in green) at half the original resolution. The output is a 2D image patch, with 
probability predictions per pixel for the center of the input image volume. A Tissue Probability Map (TPM) is added as 
extra features, which was made from averaging tumor segmentations from the training set.
Implementation Detail for 3D U-Net
The 3D U-Net also follows the implementation of Hirsch et al. (29). The U-Net is a 3D CNN with 
16 layers. The input is an image patch of dimensions 19⨯75⨯75 at full resolution (see Fig. 
3, orange square in input), which passes through all convolutional layers with 
learnable kernels of size 3⨯3⨯3 and ReLU as nonlinear activation functions. The 
layers are organized in convolutional blocks, consisting each of two convolutional 
layers, one downsampling layer in the frst half of the network, and upsampling 
layers in the second half of the network. Downsampling is performed with average 
pooling layers, and upsampling with transposed convolutional layers with fxed 
weights (see implementation of upsampling and downsampling in the U-Net). 
Residual connections concatenate the feature maps of each block on the same 
scale (see Fig. 3). The last layer has kernels of size 13 with a Softmax activation 
function, which outputs a prediction for the center 37⨯37 area of the middle 
sagittal slice of the input (see Fig. 3, black square on prediction).
Implementation and training of the DeepMedic and the U-Net were performed in Python 2.7, 
with Keras 2.3.1 using TensorFlow backend 1.14.0, and NumPy version 1.16.6. Initialization of 
the kernel weights of the DeepMedic was done with Keras’s Orthogonal initializer. The U-Net’s 
kernel weights were initialized using Keras’s default glorot uniform initializer.  Both NumPy and 
TensorFlow were seeded with seed numbers 1 and 2, respectively, for initialization of all 
random numbers.
Implementation of Upsampling and Downsampling in the U-Net
Conventional implementations of U-Net are prone to blocking artifacts (30). We carefully 
designed the downsampling and upsampling steps to avoid these artifacts. In all layers we 
selected “valid” padding, which reduced the size of the feature maps on each convolutional 
layer such that the model depth was kept relatively low at 4 downsampling blocks and 4 
upsampling blocks. Downsampling was performed using average pooling with a kernel of size 3 
and stride 2. Upsampling used a transposed convolution with fixed kernels of size 3, with fixed 
weights (0.5,1, and 0.5) to perform exact bilinear interpolation. Residual connections between 
downsampling and upsampling pathways required cropping borders by 1 voxel to match feature 
map dimensions. We note that this implementation deviates from common implementations of 
the U-Net. Typically, U-Nets use average pooling with variable kernel sizes for downsampling 
and learnable weights in the transposed convolutional layers for upsampling, but this can cause 
border and checkerboard artifacts (30). Fixing the transpose convolution parameter, as we have
done here, seems to limit the flexibility of the network while imposing additional processing 
steps; however, this is worthwhile to avoid blocking artifacts. Additionally, this reduces the 
number of trainable parameters and provides a better training starting point by ensuring artifact-
free upsampling from the start.
Network Training
The network is trained using conventional gradient descent to minimize a generalized Dice loss 
(29) using the Adam optimizer (35) (Fig. S4A and Fig. S4B). We used a batch of size 16 for 
each weight-updating iteration. The Dice score for the validation set was monitored at every 
epoch (Fig. S4C), which occurred every 2,976 weight update iterations with 48,000 image 
patches drawn from 4,800 scans per epoch. For data augmentation, each input was randomly 
rotated on one of three rotation axes. The learning rate was set to 10−6, and adapted 
automatically with the Adam optimizer (35). Learning was halted when we observed overtraining
on the validation set, which is a subset of the training data not used for training (70 exams 
selected at random containing 42 malignant scans). During training, image patches were 
presented containing tumor and non-tumor regions in a ratio of 1:4, as the benign tissue 
samples available far outweighed the malignant tissue samples available. Tumor voxels were 
sampled uniformly across all segmented slices. Non-tumor voxels were sampled anywhere in 
the benign scans, enriching for locations with high T1c values. This sampling process focused 
the training on the areas of the benign exams that are most challenging to classify due to BPE. 
No strong overfitting behavior was observed, so regularization was not applied, such as dropout
or L2 penalty.
 
Figure S4: Training curves for the network. A: Training (red) and validation (black) loss during 
training on a set of 240 malignant and 240 benign breasts showing clear signs of overfitting (the 
loss keeps decreasing on the training data (red) but starts increasing on the validation data 
(black)). B: Training (red) and validation (black) set loss on the full training set (2,555 malignant 
and 60,108 benign breasts). Both losses decrease during training, showing asymptotic behavior
and no overfitting. C: Average Dice score for both background and foreground voxels taken 
each epoch on the validation set containing 100 malignant scans. Each epoch consists of a full 
pass through all malignants in each set. 
Network Architecture Optimization
We organized the architecture optimization as a series of choices between alternative methods 
evaluated based on the Dice score of the validation set. In all comparisons that follow, we report
the number of malignant exams used for training and validation (Nt and Nv, respectively), the 
median Dice score for the two methods on the validation set, and the p-value of a paired test on 
the difference of medians. 
First, we used a MultiPrior network (29), which is a DeepMedic network (28) with additional prior
information (Fig. 3A). Specifically, it included a TPM to provide spatial priors on likely location of 
tumors and a CRF to provide morphological spatial priors. Adding this TPM improved 
performance by removing erroneous malignant voxels outside the breast (Nt = 869; Nv = 29; 
median Dice without TPM: 0.64; median Dice with TPM: 0.71; W = 80.5, p = 0.005). In contrast, 
adding a CRF did not enhance performance (median Dice without CRF: 0.75; median Dice with 
CRF: 0.72; W = 420.0, p = 0.69, N = 42), so we refrained from future use. This 3D CRF follows 
the structure of the MultiPrior model (29) implemented with a Gaussian filter and a bilateral filter,
where we chose parameters for both filter widths (variance) to be 1, and the weight constant for 
both filters equal to 1, done with a simple grid search in the interval [0-5] on a small number of 
segmentations from the validation set. We then tested the U-Net with a TPM, where the TPM 
was a simple binary breast mask (Fig. 3). We found that the U-Net + TPM architecture 
outperformed the DeepMedic + TPM (Fig. S5A, Nt = 1025; Nv=20; median Dice DeepMedic + 
TPM: 0.69; median Dice U-Net + TPM: 0.8; W=26, p =0.003). Next, we tested the U-Net without
the use of the breast mask and found that performance was unchanged (Fig. S5B, Nt = 1025; 
Nv = 20; median Dice U-Net + TPM: 0.81; median Dice U-Net: 0.82; W = 113, p = 0.93). We 
tested whether addition of the T2 scans could improve performance, however, addition of 
coregistered T2 images actually decreased Dice score performance on the validation set (Fig. 
S5C, Nt = 2,555; Nv = 42; median Dice without T2: 0.75; median Dice with T2: 0.67; W = 188.0, 
p = 0.001). Finally, we compared the nonlinear intensity harmonization procedure (as described 
in Fig. S2) with a normalization that scales intensity separately for each exam. We found no 
difference in performance (Fig. S5D, Nt = 2,555; Nv = 42; median Dice nonlinear intensity 
harmonization: 0.8; median Dice exam-based scaling: 0.81; W = 515, p = 0.16), so we adopted 
the simpler scaling technique. Adding the slope of the contrast dynamic after the first contrast 
image significantly improved performance after training for 6 epochs in a balanced set 
containing equal number of malignant and benign scans (Fig. S6E, Nt=2,400; Nv=100, median 
Dice without slopes: 0.6, median Dice with slopes: 0.66; W=1836, p=0.02).
Figure S5: Architecture optimization. Pairwise comparison of five conditions for model 
selection. A: Architecture based on the DeepMedic adding spatial priors against the U-Net. B: 
The U-Net against a U-Net using spatial information on breast tissue location. C: Addition or 
exclusion of T2-weighted scans. D: Two different methods for harmonization of voxel intensities 
in the images, namely nonlinear transformation dependent on the scanner manufacturer (see 
Fig. S2) against a simpler scaling method based on the T1-weighted scan of each exam. E: 
Benefit of addition of contrast enhancement dynamics (DCE-in, DCE-out)( * : Wilcoxon p < 
0.05).
Training with different data set size
The basic hypothesis of this work is that training a deep network with a large dataset would 
significantly improve performance so as to reach radiologist-level performance. Performance 
gains with increased training set sizes are well established in machine learning. Nonetheless, 
we wanted to test this here explicitly for the typical dataset sizes used here and in the literature. 
When training this network on a typical dataset of 240 malignant and 240 benign scans the 
network achieved a Dice score of 0.63 on a fixed validation set (N=100, Figure S4). A tenfold 
larger training set with 2,400 malignant and 2,400 benign scans achieved a Dice score of 0.69 
in the same fixed validation set. Finally the validation Dice score on the full data set with two 
order of magnitude more benign scans (2,455 malignant and 60,108 benigns) was of 0.73 
(Figure S4). Both these gains in performance on a validation set were statistically significant 
(N=100, W=940, p=0.001 small vs medium, N=100, W=1230, p=0.03 medium vs large). 
Performance on this validation set (that is part of the training set) is lower than on the test set 
(compare with Fig. S6 with Fig. 4). The reason for this is that the test set contains more detailed 
segmentations necessary for multifocal lesions.  
Figure S6: Performance comparison over three different training set sizes: Each of the sets has
the same scans used for validation (100 malignants and 100 benigns) and testing (250 
malignants), varying only the amount for training: The number of malignant/benign scans 
available in each set are: 240/240 in the small set, 2,400/2,400 for the medium set, and 
2,455/60,108 in the large (complete) set. The median Dice score is 0.66, 0.69 and 0.73 
respectively (* indicates a pairwise significant difference between each group). 
Using a Consensus Segmentation as Reference
To evaluate the performance on the test set, we constructed a reference segmentation by 
combining the segmentations of multiple radiologists. To prevent bias, this consensus 
segmentation did not include the segmentation of the radiologist being evaluated. Thus, each of 
the four radiologists had a separate reference segmentation that excluded the segmentation of 
the radiologist being tested. We used the intersection to combine the segmentations of the three
other radiologists, including only voxels on which all three agreed. The exact boundary of the 
tumor in the automated segmentation is dependent on the threshold applied to the output 
probabilities. ROC curves for different thresholds are shown in Figure 5A and Fig S7A. To select
the best threshold we computed the Dice score at different thresholds averaged over the four 
references (Fig. S7B) on a small portion of the test data (N = 16) selected at random. The best 
threshold value in Figure S7B was 0.60. Note that this threshold is relative to the maximum 
value in a test slice as described in the Methods section (primary outcome measure). This 
relative threshold implements the prior knowledge (available to both the machine and the 
radiologist) that the 2D slice contains a malignant lesion.
Figure S7: Network performance as a function of threshold of the network output. A: ROC curves for 
Ref2–Ref4 on 266 test cases (blue) and average ROC (black). Corresponding AUC were 0.996, 0.995, 
and 0.995, respectively. The performance of radiologists R2–R4 are shown as red diamonds. B: Dice 
score averaged over the four references and a subset of the test exams (N = 16) for different threshold 
values. 
Figure S8: Segmentation performance of the network depends on BPE and type of tumor.
A: For each tumor type, the performance of the model is displayed, and the median is marked 
with a black line (ANOVA, F = 2.12, p = 0.004, df = 262). B: Histograms showing Dice scores for
the network, depending on the strength of BPE as assessed in the radiology reports. Radiologist
performance is not affected by breast density (not shown), whereas the model’s performance 
decays in the presence of strong BPE (median Dice <75% BPE: 0.79; median Dice  > 75% 
BPE: 0.73; U = 2592; p = 0.02, Mann Whitney-U).
